To determine the impact on clinical management of patients with high-risk (HR) prostate cancer at diagnosis and patients with biochemical recurrence (BCR) using 68Ga-THP-PSMA PET-CT
Latest Information Update: 04 Jun 2021
At a glance
- Drugs Gallium-68-THP PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 04 Jun 2021 New trial record